Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing only hyaluronic acid and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine and phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lidocaine in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lidocaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only domiphen and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and prilocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine in gingival dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone and lidocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Cetylpyridinium and lidocaine only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and methylprednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 50 microgram/mg cutaneous patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 50 microgram/mg cutaneous patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline and lidocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and prilocaine only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing lidocaine and prilocaine in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline- and lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 150 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 150 milligram/1 gram conventional release cutaneous spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lidocaine and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and nifedipine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine and nifedipine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Product containing only lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Product containing benzoxonium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Benzoxonium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzoxonium and lidocaine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Benzoxonium and lidocaine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing glucose and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing glucose and lidocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Glucose and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Glucose and lidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and chlorocresol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Cetylpyridinium and chlorocresol and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Product containing cetylpyridinium and chlorocresol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
3 |
Chlorhexidine and lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing chlorhexidine and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and naphazoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine- and naphazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine- and naphazoline-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only aminoacridine and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing aminoacridine and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |